Lupin Limited has received marketing approval for its biosimilar pegfilgrastim in India, aiding in chemotherapy recovery. The ...

Sandoz, the Swiss drugmaker, aims to double its annual net sales by 2035, focusing on biosimilars. The company plans to ...

Bristol Myers Squibb announces its experimental cell therapy, arlocabtagene autoleucel, met key goals in a mid-stage trial ...

The US health department has officially appointed Michael Davis and Karim Mikhail as permanent heads of the FDA’s drug and ...

Amgen's Imdelltra combined with AstraZeneca's Imfinzi shows significant improvement in overall and progression-free survival ...

In a significant ruling, the Supreme Court of India has dismissed Sanofi's petition against a CBI complaint involving alleged ...

Roivant's experimental drug mosliciguat has demonstrated significant efficacy in treating pulmonary hypertension linked to ...

Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...

Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...

Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...

Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...

New Zealand's health authorities have granted approval for the use of MDMA in treating severe PTSD, making it only the second ...